Page 2 - நல்ல விநியோகம் ப்ர்யாக்டிஸஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Text Size: A+ New Delhi: Lack of adherence to “proper guidelines” is responsible for counterfeiting of drugs, loss of revenue and market share for Indian pharmaceutical industry, according to a whitepaper released by a lobby of foreign drug makers, the Organisation of Pharmaceutical Producers of India (OPPI). The whitepaper was the result of a joint research conducted by the OPPI and Nexdigm (SKP), a multidisciplinary group that helps global organisations meet the needs of a dynamic business environment. The paper, titled ‘ Good Distribution Practices for Pharmaceutical Products’, highlighted loopholes in the distribution chain of pharma products in India and also suggested remedial measures 

United statesNew delhiNimish shahCorporate servicesPics pharmaceutical inspection convention schemeDrug administrationPfizer ltdOrganisation of pharmaceutical producers indiaPharmaceutical producersGood distribution practicesPharmaceutical productsNovartis indiaNovo nordisk indiaDrugs controller generalSupply chain security actPharmaceutical inspection convention scheme